Catalyst Crew Technologies Corp. (OTC: CCTC), an artificial intelligence-driven healthcare technology company, announced on April 30, 2026, that its Chief Executive Officer, Kevin Roldan Levy, has initiated a capital structure initiative. Under the plan, up to fifty percent of his restricted common stock holdings are expected to be canceled in exchange for a newly designated class of preferred equity. This move is intended to optimize the company's common equity base, enhance long-term strategic flexibility, and align executive equity participation with broader corporate development goals.
The company believes the transaction will contribute to a more disciplined equity framework and support its evolving long-term strategic initiatives, including future financing opportunities, strategic partnerships, and operational development. By reducing the outstanding common shares, the initiative is expected to strengthen alignment between executive leadership and long-term corporate performance objectives, reinforcing management's commitment to disciplined growth and shareholder-oriented development.
Kevin Roldan Levy, CEO of Catalyst Crew Technologies, stated, "This initiative reflects my long-term commitment to the Company's strategic development and disciplined capital structure management. As we continue advancing our broader healthcare technology strategy, I believe proactive capital structure planning will support stronger long-term positioning while reinforcing our commitment to sustainable shareholder value creation."
The company is currently finalizing the structure and designation of the new preferred equity as part of the implementation process and expects to provide additional updates as final corporate actions are completed. Catalyst Crew continues to advance its transition into AI-enabled healthcare, with a focus on telehealth infrastructure, remote patient monitoring, and data-driven clinical insights across underserved markets.
The company will continue to evaluate strategic initiatives designed to support its long-term development and will provide additional updates as appropriate. For more information, please visit https://catalystcrewai.com or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
Catalyst Crew Technologies Corp. is an artificial intelligence-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The company is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination.
